Browsing Journal Articles by Subject "Azitromicina"
Now showing items 1-6 of 6
-
Acute generalized exanthematous pustulosis during puerperal period induced by azithromycin : case report
(2018) [Journal article]Background: The use of antibiotics, especially beta-lactams and macrolides, may be associated with dermatopathies, such as Acute Generalized Exanthematous Pustulosis (AGEP), which is an uncommon cutaneous adverse reaction. ... -
Antibiotic therapy for pelvic inflammatory disease
(2017) [Journal article]Background Pelvic inflammatory disease (PID) is an infection that affects 4% to 12% of young women, and is one of the most common causes of morbidity in this age group. The main intervention for acute PID is the use of ... -
Comparação entre a azitromicina e a amoxicilina no tratamento da exacerbação infecciosa da doença pulmonar obstrutiva crônica
(2007) [Journal article]Objetivo: Comparar a eficácia, segurança e tolerabilidade da azitromicina e da amoxicilina no tratamento de pacientes com quadro clínico de exacerbação infecciosa da doença pulmonar obstrutiva crônica. Métodos: Seis centros ... -
Efficacy of azithromycin and miltefosine in experimental systemic pythiosis in immunosuppressed mice
(2019) [Journal article]We evaluated the efficacy of azithromycin (50 mg/kg, every 12 h [q12h] orally) and miltefosine (25 mg/kg, q24h orally) treatments in an experimental model of vascular/disseminated pythiosis in immunosuppressed mice. ... -
Photo-mediated and advanced oxidative processes applied for the treatment of effluents with drugs used for the treatment of early COVID-19 : review
(2021) [Journal article]The COVID-19 pandemic is proving to be one of the most challenging health and social crises ever faced by humanity. Several drugs have been proposed as potential antiviral agents for the treatment of COVID-19 since the ... -
Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency
(2022) [Journal article]Off-label use of azithromycin, hydroxychloroquine, and ivermectin (the "COVID kit") has been suggested for COVID-19 treatment in Brazil without clinical or scientific evidence of efficacy. These drugs have known adverse ...